If you need more lookups,
subscriptions start at $34 USD/month.
Steen Lisby Location
Hørsholm, DK
Steen Lisby Work
Chief Medical Officer @ (February 2025 - Present)
Company Owner @ SL Medical Consult (June 2024 - Present)
Chief Scientific Officer, Global Head translational Medicine @ Y-mAbs Therapeutics A/S (June 2020 - April 2024)
SVP, Chief Medical Officer @ (July 2017 - June 2020)
Vice President, Medical @ (April 2015 - June 2017)
Senior Medical Director, Medical lead @ (October 2014 - March 2015)
Senior Medical Director @ (July 2010 - October 2014)
Medical Director @ (July 2008 - June 2010)
Director @ (March 2007 - July 2008)
Steen Lisby Education
Københavns Universitet - University of Copenhagen
MD (DMSc, Medicine)
Steen Lisby Skills
Oncology
Pharmaceutical Industry
Hematology
Medical Affairs
Biotechnology
Antibodies
GCP
Medicine
Senior Medical Director
early stage clinical trials
Pharmacovigilance
late stage clinical development
Monoclonal Antibodies
Line Management Experience
Translational Medicine
Physicians
Biotechnology Industry
Biotherapeutics
Psoriasis
Medical Directors
Medical Officer
Pharmacueticals
ADCs
Autoimmune Diseases
Dermatology
antibody drug conjugates
Immunodermatology
Medical Director
first in human clinical trial
Clinical Development
Clinical Research
Clinical Trials
Drug Development
Microsoft Office
Team Building
Hospitals
Requirements Analysis
Management
Business Development
Business Strategy
Strategic Planning
Business Analysis
Customer Service
Steen Lisby Summary
Steen Lisby, based in Hørsholm, DK, is currently a Chief Medical Officer at Myricx Bio. Steen Lisby brings experience from previous roles at SL Medical Consult, Y-mAbs Therapeutics A/S, Y-mAbs Therapeutics, Inc. and Genmab A/S. Steen Lisby holds a MD in DMSc, Medicine @ Københavns Universitet - University of Copenhagen. With a robust skill set that includes Oncology, Pharmaceutical Industry, Hematology, Medical Affairs, Biotechnology and more. Steen Lisby has 2 emails on RocketReach.
Looking for a different Steen Lisby?
Find contact details for 700 million professionals.